Coexpression cluster:C332

Full id: C332_Fibroblast_Smooth_Mesenchymal_mesenchymal_Chondrocyte_Skeletal_Pericytes

Phase1 CAGE Peaks

Hg19::chr2:238233052..238233077,-	p@chr2:238233052..238233077 -
Hg19::chr2:238233102..238233125,-	p@chr2:238233102..238233125 -
Hg19::chr2:238233169..238233193,-	p@chr2:238233169..238233193 -
Hg19::chr2:238233200..238233214,-	p@chr2:238233200..238233214 -
Hg19::chr2:238233221..238233252,-	p@chr2:238233221..238233252 -
Hg19::chr2:238233270..238233287,-	p@chr2:238233270..238233287 -
Hg19::chr2:238233328..238233343,-	p@chr2:238233328..238233343 -
Hg19::chr2:238233367..238233381,-	p@chr2:238233367..238233381 -
Hg19::chr2:238233399..238233412,-	p@chr2:238233399..238233412 -
Hg19::chr2:238243426..238243476,-	p5@COL6A3
Hg19::chr2:238245036..238245087,-	p@chr2:238245036..238245087 -
Hg19::chr2:238245089..238245122,-	p@chr2:238245089..238245122 -
Hg19::chr2:238245140..238245185,-	p@chr2:238245140..238245185 -
Hg19::chr2:238247690..238247710,-	p@chr2:238247690..238247710 -
Hg19::chr2:238249113..238249142,-	p11@COL6A3
Hg19::chr2:238267705..238267736,-	p@chr2:238267705..238267736 -
Hg19::chr2:238267881..238267893,-	p@chr2:238267881..238267893 -
Hg19::chr2:238268028..238268038,-	p25@COL6A3
Hg19::chr2:238269787..238269823,-	p@chr2:238269787..238269823 -
Hg19::chr2:238270402..238270421,-	p7@COL6A3
Hg19::chr2:238271931..238271942,-	p@chr2:238271931..238271942 -
Hg19::chr2:238271947..238271972,-	p@chr2:238271947..238271972 -
Hg19::chr2:238275490..238275526,-	p@chr2:238275490..238275526 -
Hg19::chr2:238277500..238277511,-	p17@COL6A3
Hg19::chr2:238277567..238277581,-	p9@COL6A3
Hg19::chr2:238289803..238289845,-	p@chr2:238289803..238289845 -
Hg19::chr2:238289886..238289905,-	p@chr2:238289886..238289905 -
Hg19::chr2:238289901..238289937,+	p@chr2:238289901..238289937 +
Hg19::chr2:238305397..238305434,-	p10@COL6A3
Hg19::chr2:238322770..238322791,-	p2@COL6A3
Hg19::chr2:238322800..238322824,-	p1@COL6A3
Hg19::chr2:238322913..238322923,-	p12@COL6A3
Hg19::chr2:238322924..238322940,-	p6@COL6A3
Hg19::chr2:238322983..238323006,-	p4@COL6A3
Hg19::chr2:238323007..238323038,-	p3@COL6A3

Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data

---

No results for this coexpression

Enriched Gene Ontology terms on this co-expression cluster<b>Summary:</b> Results for GOStat analysis on co-expressed clusters. Each cluster with promoters mapping to at least two different genes was analysed with GOStat (PMID: 14962934) with default parameter. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br>data

---

No GOStat results

Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br>cell_data<br>uberon_data<br>disease_data<br>

---

Cell Type

Ontology term	p-value	n
fibroblast	2.40e-34	76
multi fate stem cell	3.67e-19	427
contractile cell	6.70e-19	59
muscle precursor cell	6.91e-19	58
myoblast	6.91e-19	58
multi-potent skeletal muscle stem cell	6.91e-19	58
somatic stem cell	4.50e-18	433
muscle cell	5.42e-18	55
stem cell	1.10e-16	441
electrically responsive cell	1.39e-14	61
electrically active cell	1.39e-14	61
skin fibroblast	1.15e-13	23
non-terminally differentiated cell	3.95e-13	106
smooth muscle cell	1.13e-12	43
smooth muscle myoblast	1.13e-12	43
connective tissue cell	4.28e-10	361
somatic cell	1.47e-08	588
mesenchymal stem cell of adipose	3.51e-08	8
stromal cell	4.91e-08	28
mesenchymal cell	5.02e-08	354
vascular associated smooth muscle cell	2.19e-07	32
cardiocyte	9.63e-07	16

Uber Anatomy

Ontology term	p-value	n
somite	1.46e-22	71
presomitic mesoderm	1.46e-22	71
presumptive segmental plate	1.46e-22	71
dermomyotome	1.46e-22	71
trunk paraxial mesoderm	1.46e-22	71
dense mesenchyme tissue	1.84e-22	73
paraxial mesoderm	6.11e-22	72
presumptive paraxial mesoderm	6.11e-22	72
muscle tissue	7.30e-20	64
musculature	7.30e-20	64
musculature of body	7.30e-20	64
skeletal muscle tissue	2.22e-19	62
striated muscle tissue	2.22e-19	62
myotome	2.22e-19	62
epithelial vesicle	2.63e-19	78
multilaminar epithelium	4.57e-18	83
trunk mesenchyme	4.12e-14	122
mesenchyme	1.38e-13	160
entire embryonic mesenchyme	1.38e-13	160
surface structure	3.95e-11	99
integument	4.13e-11	46
integumental system	4.13e-11	46
connective tissue	1.31e-10	371
mesoderm	5.61e-10	315
mesoderm-derived structure	5.61e-10	315
presumptive mesoderm	5.61e-10	315
skin of body	2.06e-09	41
unilaminar epithelium	1.65e-08	148
primary circulatory organ	1.25e-07	27
tissue	1.54e-07	773
organism subdivision	2.04e-07	264
trunk	2.08e-07	199
heart	4.34e-07	24
primitive heart tube	4.34e-07	24
primary heart field	4.34e-07	24
anterior lateral plate mesoderm	4.34e-07	24
heart tube	4.34e-07	24
heart primordium	4.34e-07	24
cardiac mesoderm	4.34e-07	24
cardiogenic plate	4.34e-07	24
heart rudiment	4.34e-07	24
musculoskeletal system	7.41e-07	167

Disease

Ontology term	p-value	n
ovarian cancer	2.43e-07	14

Overrepresented TFBS (DNA) motifs on this co-expression cluster<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data

---

Novel motifs

JASPAR motifs

Motifs	-log10(p-value)
{{{tfbs_overrepresentation_jaspar}}}

ENCODE TF ChIP-seq peak enrichment analysis<b>Summary:</b> For each TF and each co-expression cluster, the number of promoters with ENCODE TF ChIP signal was compared with the rest of promoters from the robust set using Fisher's exact test. Clusters with significant ChIP enrichment (q <= 0.05) after Benjamini-Hochberg correction were retained. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br><br>data

---

No analysis results for this cluster

Relative expression of the co-expression cluster<b>Summary:</b>Co-expression clusters are compared against FANTOM5 samples to obtain relative expression. <br><b>Analyst:</b>NA<br><br>link to data source<br> data

---

This analysis result is provided for C0 - C305 clusters.